Skip to search formSkip to main contentSkip to account menu

S 15176

Known as: N-((3,5-di-tert-butyl-4-hydroxy-1-thiophenyl))-3-propyl-N'-(2,3,4-trimethoxybenzyl)piperazine, S-15176 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Piperazines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
S-15176 and its methylated derivative suppress the CsA-insensitive mitochondrial permeability transition and subsequent cytochrome c release induced by silver ion, and show weak protonophoric…
A recent report has described that S-15176 (N-((3,5-di-tert-butyl-4-hydroxy-1-thiophenyl))-3-propyl- N 0 -(2,3,4-trimethoxybenzyl… 
2006
2006
Effect of the mitochondrial transition pore inhibitor, S-15176, on rat liver mitochondria: ATP synthase modulation and mitochondrial uncoupling induction.
Review
2002
Review
2002
The Use of Partial Fatty Acid Oxidation Inhibitors for Metabolic Therapy of Angina Pectoris and Heart Failure
Background: Partial fatty acid oxidation inhibitors have raised great interest since they are expected to counteract a… 
2000
2000
S-15176 reduces the hepatic injury in rats subjected to experimental ischemia and reperfusion.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)